About the Project
The GW4 BioMed3 Doctoral Landscape Programme is offering up to 18 MRC funded studentships across a range of biomedical disciplines, with a start date of October 2027.
These four-year studentships provide funding for fees and stipend at the rate set by the UKRI, as well as other research training and support costs, and are available to UK and International students.
About the GW4 BioMed3 Doctoral Landscape Programme
The partnership brings together the Universities of Bath, Bristol, Cardiff (lead), and Exeter to train, support and develop graduates with strong research, critical analysis, creative problem solving and translational skills, equipping them for careers in the UK and globally. Our vision aligns research and skills development with UK Government priorities for the life sciences sector, while nurturing contributions to improve health outcomes and the economy worldwide.
Students will have access to the combined research strengths, training expertise, and resources of the four research-intensive universities, with opportunities to participate in interdisciplinary science. GW4 BioMed has previously awarded over 100 studentships across 6 cohorts in its first phase, along with 99 students over 5 cohorts in its second phase. GW4 BioMed3 will be our third, starting in October 27.
This project is in competition for place with the projects across the MRC GW4 BioMed3 Doctoral Landscape Award studentships. There are a total of 18 studentships available across the partnership.
The 134 projects available for application, are aligned to the following themes;
- Cardiometabolic Disease
- Infection, Immunity, and Antimicrobial Resistance
- Neuroscience and Mental Health
- Population Health Sciences
Applications open on Wednesday 9th September and close at 5.00pm on Wednesday 21st October 2026. Please note that we may close the application process before the stated deadline if an unprecedented number of applications are received– check our website for details.
Studentships will be 4 years full time. Part-time study may also be available.
Project Information
Antimicrobial resistance is a major threat to modern medicine, and bacteriophage therapy is a promising route to treat drug-resistant infections. Yet phage therapy can fail when bacteria evolve resistance or deploy defence systems that block infection. This project will ask how antibiotics reshape phage-bacteria interactions, resistance evolution, and cell-to-cell variation in bacterial responses. The student will combine experimental evolution, microbiology, single-cell imaging and biochemistry, working across Exeter, Bath and Bristol. Patient and public involvement will help keep the project focused on clinically relevant questions and the future use of phage therapy.
For further information or to apply click here: https://www.exeter.ac.uk/study/funding/award/?id=5932
Funding Notes
A GW4 BioMed3 MRC DTP studentship includes full UK tuition fees, a stipend at the minimum UKRI rate (£21,805 p.a for 2026/27 updated each year). Additional Research & Training Support funding of up to £5,000 per annum is also available. Funding arrangements will be adjusted pro-rata for part-time studentships.